- Home
- CELC vs TCMD Comparison
CELC vs TCMD Comparison
Compare CELC & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | TCMD |
|---|---|---|
| Founded | 2011 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 300.1M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CELC | TCMD |
|---|---|---|
| Price | $105.07 | $27.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $100.13 | $23.25 |
| AVG Volume (30 Days) | ★ 945.1K | 414.3K |
| Earning Date | 11-12-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.66 |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $311,513,000.00 |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $8.83 |
| P/E Ratio | ★ N/A | $36.29 |
| Revenue Growth | N/A | ★ 9.28 |
| 52 Week Low | $7.58 | $8.61 |
| 52 Week High | $112.64 | $29.49 |
Technical Indicators
Market Signals| Indicator | CELC | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 68.80 |
| Support Level | $100.00 | $24.54 |
| Resistance Level | $108.91 | $29.49 |
| Average True Range (ATR) | 5.14 | 0.96 |
| MACD | -0.88 | -0.11 |
| Stochastic Oscillator | 54.47 | 64.64 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.